FDA Adverse Event Malfunction Summary report: N

FOLFUSOR

MDR report key: 2770931 · Received October 3, 2012

Report

Report Number
1416980-2012-01495
Event Type
Malfunction
Date Received
October 3, 2012
Date of Event
September 1, 2012
Report Date
September 12, 2012
Manufacturer
BAXTER HEALTHCARE - IRVINE
Product Code
MEB
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHARMACIST

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION SUMMARY: BAXTER RECEIVED ONE SAMPLE FOR EVALUATION. THE REPORTED CONDITION OF A RUPTURED RESERVOIR WAS CONFIRMED. VISUAL EXAMINATION OF THE UNIT DETERMINED THAT THE RESERVOIR RUPTURED IN A FOOTED POSITION. ADDITIONALLY, MICROSCOPIC EXAMINATION OF THE RESERVOIR REVEALED INTERNAL DAMAGE NEAR THE RUPTURE LINE. THE ROOT CAUSE WAS DETERMINED TO BE A MANUFACTURING ISSUE. NO REPAIR WAS DONE, AS THIS IS A SINGLE-USE DEVICE WHICH WILL BE DISCARDED. NO OTHER OBSERVATIONS WERE NOTED ON THE UNIT. THIS PRODUCT IS NOT DISTRIBUTED IN THE US AND DOES NOT HAVE A 510(K) NUMBER. THE BATCH REVIEW REVEALED THAT ALL OF THE ACCEPTANCE CRITERIA WERE MET TO RELEASE THE LOT. THERE WERE NO NON-CONFORMANCES, FAILURES, REWORK, OR DEVIATIONS RELATED TO THE LOT. THERE WERE NO CHANGES TO SPECIFICATIONS, TEST METHODS, PROCESS, EQUIPMENT, OR RAW MATERIALS THAT COULD BE ASSOCIATED WITH THE REPORTED CONDITION.

Description of Event or Problem · 1

BAXTER (B)(4) RECEIVED A REPORT THAT A FOLFUSOR HAD A RESERVOIR RUPTURE AT THE END OF PATIENT INFUSION. THE DEVICE WAS FILLED WITH A SOLUTION CONTAINING FLUOROURACIL. THIS CONDITION INTERRUPTED THERAPY. THERE WAS PATIENT INVOLVEMENT, BUT THERE WAS NO REPORT OF PATIENT INJURY, MEDICAL INTERVENTION NECESSARY, OR ADVERSE REACTION IN ASSOCIATION WITH THIS EVENT. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FOLFUSOR PUMP, INFUSION, ELASTOMERIC MEB BAXTER HEALTHCARE - IRVINE 11G029

Patients

Seq Age Sex Outcome Treatment
1 FLUOROURACIL